SentinelOne and DEKA: Leaders in Innovative Laser Technology Advancing Healthcare Solutions

### DEKA's Expanding Footprint in Laser Technology

DEKA, a subsidiary of El.En. group, continues to establish its prominence in the laser technology arena, particularly within aesthetic medicine and surgery. Founded in 1996, DEKA has consistently been at the forefront of innovation, developing a portfolio of medical devices that cater to the evolving needs of healthcare professionals. The company's latest advancements include the introduction of artificial intelligence-powered technologies, such as Lipo AI™ for lipolysis and the hybrid TORO™ system. These innovations not only enhance the effectiveness of medical procedures but also signify a shift towards more intelligent, data-driven healthcare solutions.

The recent inauguration of DEKA's new offices in Lyon represents a strategic expansion into the French and Maghreb markets. This initiative is crucial for showcasing DEKA's cutting-edge medical devices, including their micro-ablative and sub-ablative CO2 laser systems. These technologies are designed to minimize patient downtime, a feature that is particularly appealing in today's fast-paced medical landscape. During the launch event, attended by key executives including CEO Ing. Paolo Salvadeo and International Sales Director Dr. Giustino Gallo, the focus was on DEKA's commitment to providing safe and effective solutions that yield optimal results for clients, reinforcing the company's position as a leader in the laser technology sector.

DEKA's CO2 laser solutions, particularly the CoolPeel™ procedure, are gaining recognition for their efficiency and ability to facilitate rejuvenation treatments with minimal disruption to patients' everyday lives. The versatility of DEKA's technology extends across multiple medical fields, including dermatology, gynecology, and proctology, showcasing its precision and selectivity. With a strong emphasis on continuous research and strategic partnerships, DEKA is well-positioned to further influence the landscape of laser applications in medicine, ensuring that it remains a pivotal player in the industry.

In addition to its technological advancements, DEKA emphasizes the importance of client investment outcomes. General Manager Emmanuel Maroselli highlights the company's dedication to providing solutions that not only enhance patient care but also deliver strong returns for healthcare providers. This dual focus on innovation and economic viability underlines DEKA's commitment to supporting the broader healthcare community.

As DEKA continues to expand its reach and refine its technologies, the company is set to redefine standards in laser applications, solidifying its reputation as a trusted leader in medical innovations.